Insider Transactions in Q4 2025 at Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 27
2025
|
Yuval Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,973
-6.1%
|
$152,541
$17.14 P/Share
|
|
Oct 27
2025
|
Yuval Cohen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,973
+5.75%
|
$35,892
$4.26 P/Share
|
|
Oct 24
2025
|
Sean F. Moran Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,981
-15.04%
|
$220,677
$17.02 P/Share
|
|
Oct 24
2025
|
Sean F. Moran Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,981
+13.08%
|
$51,924
$4.26 P/Share
|
|
Oct 24
2025
|
Yuval Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,660
-11.9%
|
$317,220
$17.01 P/Share
|
|
Oct 24
2025
|
Yuval Cohen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,660
+10.63%
|
$74,640
$4.26 P/Share
|
|
Oct 20
2025
|
Anne Altmeyer |
SELL
Open market or private sale
|
Direct |
1,060
-14.62%
|
$21,200
$20.5 P/Share
|
|
Oct 20
2025
|
Anne Altmeyer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,060
+12.75%
|
$4,240
$4.8 P/Share
|